Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Joyce Yamashiro"'
Autor:
Lin Lin, Nathanael Kane, Robert E. Reiter, Joyce Yamashiro, Evelyn A. Kono, Nicholas G. Nickols, Naoko Kobayashi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(5)
Purpose: The use of high-dose per fraction radiotherapy delivered as stereotactic body radiotherapy is a standard of care for prostate cancer. It is hypothesized that high-dose radiotherapy may enhance or suppress tumor-reactive immunity. The objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47d5f5d58dc7adec892ff5d81c77823
https://pubmed.ncbi.nlm.nih.gov/33219015
https://pubmed.ncbi.nlm.nih.gov/33219015
Autor:
Ziyue Karen Jiang, Robert E. Reiter, Chun Wang, Mo Zhang, Evelyn A. Kono, Kirstin A. Zettlitz, Naoko Kobayashi, Anna M. Wu, Johnny Guan, Wen-Ting K Tsai, Chau P. Tran, Joyce Yamashiro
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(1)
Purpose: The inability to intraoperatively distinguish primary tumor, as well as lymphatic spread, increases the probability of positive surgical margins, tumor recurrence, and surgical toxicity. The goal of this study was to develop a tumor-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496c5b99e1cec00c58823d6da2583ad7
https://pubmed.ncbi.nlm.nih.gov/30301826
https://pubmed.ncbi.nlm.nih.gov/30301826
Autor:
Robert E. Reiter, D. Seiler, Joyce Yamashiro, Gentao Liu, Junying Zheng, Shunyou Wang, Jiaoti Huang, Gang Zeng
Publikováno v:
The Prostate. 73:1378-1390
BACKGROUND Prostate cancer stem cells (PCSC) offer theoretical explanations to many clinical and biological behaviors of the disease in human. In contrast to approaches of using side populations and cell-surface markers to isolate and characterize th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dce8319afe5c72315eca6577bc22d1ed
https://doi.org/10.1002/pros.22685
https://doi.org/10.1002/pros.22685
Autor:
Hiroshi Tanaka, Martin E. Gleave, Ladan Fazli, Steven Horvath, Robert Wada, Robert E. Reiter, Jiaoti Huang, Hideyo Miyazaki, Jaibin An, Zev A. Wainberg, Evelyn A. Kono, Chau P. Tran, Tatsuya Shimomura, Robert L. Vessella, Joyce Yamashiro, Matthew Rettig
Publikováno v:
Nature Medicine. 16:1414-1420
The transition from androgen-dependent to castration-resistant prostate cancer (CRPC) is a lethal event of uncertain molecular etiology. Comparing gene expression in isogenic androgen-dependent and CRPC xenografts, we found a reproducible increase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68629741f47d30b08bb0e95f28a5dae6
https://doi.org/10.1038/nm.2236
https://doi.org/10.1038/nm.2236
Autor:
Evelyn A. Kono, Chun Wang, Robert E. Reiter, Joyce Yamashiro, Kirstin A. Zettlitz, Anna M. Wu, Naoko Kobayashi, Keyu Li
Publikováno v:
Cancer Research. 78:1775-1775
Enzalutamide (ENZ) is an androgen receptor (AR) antagonist that targets various stages of the AR signaling pathway, and approved for the treatment of castration resistant prostate cancer (CRPC). Studies show increased survival in men with metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::134f6cf899d4acb083da8c1492c91c67
https://doi.org/10.1158/1538-7445.am2018-1775
https://doi.org/10.1158/1538-7445.am2018-1775
Publikováno v:
Cancer Research. 78:5901-5901
Neuroendocrine and Small Cell Prostate Cancer (NEPC) is a lethal disease emerging from Castrate Resistant Prostate Cancer (CRPC) after treatment with next-generation anti-androgen therapies such as abiraterone and enzalutamide. The mechanisms by whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65ec139f8b10703c5da322632c7baa8e
https://doi.org/10.1158/1538-7445.am2018-5901
https://doi.org/10.1158/1538-7445.am2018-5901
Autor:
Della Z. Hu, Naoko Kobayashi, Evelyn A. Kono, Wang Chun, Anna M. Wu, Kirstin A. Zettlitz, Robert E. Reiter, Joyce Yamashiro
Publikováno v:
Clinical Cancer Research. 24:A52-A52
Introduction: Recent advances improved survival in men with metastatic castration-resistant prostate cancer (CRPC) after chemotherapy when treated with androgen ablation therapies, including the well-known androgen receptor (AR) antagonist enzalutami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbec5401e37f9c4f439629d5bfcea3e3
https://doi.org/10.1158/1557-3265.tcm17-a52
https://doi.org/10.1158/1557-3265.tcm17-a52
Autor:
Robert E. Reiter, Zhennan Gu, Joyce Yamashiro, Frederick J. Dorey, Shintaku Ip, George Thomas, Massimo Loda, Owen N. Witte, Arthur B. Raitano, Jonathan W. Said
Publikováno v:
Oncogene. 19:1288-1296
Prostate stem cell antigen (PSCA) is a recently defined homologue of the Thy-1/Ly-6 family of glycosylphosphatidylinositol (GPI)-anchored cell surface antigens. PSCA mRNA is expressed in the basal cells of normal prostate and in more than 80% of pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ca96d8525ab02cd008b15a8be61fcb
https://doi.org/10.1038/sj.onc.1203426
https://doi.org/10.1038/sj.onc.1203426
Autor:
Kinga Szigeti, Sazuku Nisitani, Matthew I. Wahl, Tetsuro Watabe, Joyce Yamashiro, Owen N. Witte, Michelle M. Le Beau, George Thomas, Zhennen Gu, Elizabeth M. Davis, Massimo Loda, Robert E. Reiter
Publikováno v:
Proceedings of the National Academy of Sciences. 95:1735-1740
The identification of cell surface antigens is critical to the development of new diagnostic and therapeutic modalities for the management of prostate cancer. Prostate stem cell antigen (PSCA) is a prostate-specific gene with 30% homology to stem cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12352c809e780aaf81ef1e69fe26c504
https://doi.org/10.1073/pnas.95.4.1735
https://doi.org/10.1073/pnas.95.4.1735
Publikováno v:
Experimental Cell Research. 239:169-174
Sodium phenylacetate (NaPA) has been shown to synergize with retinoic acid (RA) in inducing the differentiation of human neuroblastoma cells. Our studies indicated that NaPA can impact on the RA differentiation program by upregulating nuclear retinoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::898a7e4bdafcc0ffd5cf3f15a6d125da
https://doi.org/10.1006/excr.1997.3889
https://doi.org/10.1006/excr.1997.3889